These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 25611180)

  • 21. Genetic and cellular modifiers of oxidative stress: what can we learn from fatty acid oxidation defects?
    Olsen RK; Cornelius N; Gregersen N
    Mol Genet Metab; 2013; 110 Suppl():S31-9. PubMed ID: 24206932
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Animal models of chronic lung infection with Pseudomonas aeruginosa: useful tools for cystic fibrosis studies.
    Kukavica-Ibrulj I; Levesque RC
    Lab Anim; 2008 Oct; 42(4):389-412. PubMed ID: 18782827
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A membrane lipid imbalance plays a role in the phenotypic expression of cystic fibrosis in cftr(-/-) mice.
    Freedman SD; Katz MH; Parker EM; Laposata M; Urman MY; Alvarez JG
    Proc Natl Acad Sci U S A; 1999 Nov; 96(24):13995-4000. PubMed ID: 10570187
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long-term docosahexaenoic acid therapy in a congenic murine model of cystic fibrosis.
    Beharry S; Ackerley C; Corey M; Kent G; Heng YM; Christensen H; Luk C; Yantiss RK; Nasser IA; Zaman M; Freedman SD; Durie PR
    Am J Physiol Gastrointest Liver Physiol; 2007 Mar; 292(3):G839-48. PubMed ID: 17095751
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Relation between gene mutations and pancreatic exocrine function in patients with cystic fibrosis].
    Radivojević D; Guć-Sćekić M; Djurisić M; Lalić T; Minić P; Kanavakis E
    Srp Arh Celok Lek; 2001; 129 Suppl 1():6-9. PubMed ID: 15637983
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cystic fibrosis transmembrane conductance regulator (CFTR) gene mutations in pancreatitis.
    Ooi CY; Durie PR
    J Cyst Fibros; 2012 Sep; 11(5):355-62. PubMed ID: 22658665
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cystic fibrosis: need for mass deployable screening methods.
    Sengar AS; Agarwal A; Singh MK
    Appl Biochem Biotechnol; 2014 Oct; 174(3):1127-36. PubMed ID: 24880895
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cystic fibrosis: evidence for gut inflammation.
    Munck A
    Int J Biochem Cell Biol; 2014 Jul; 52():180-3. PubMed ID: 24548777
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Aggregates of mutant CFTR fragments in airway epithelial cells of CF lungs: new pathologic observations.
    Du K; Karp PH; Ackerley C; Zabner J; Keshavjee S; Cutz E; Yeger H
    J Cyst Fibros; 2015 Mar; 14(2):182-93. PubMed ID: 25453871
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Accumulation of ceramide in the trachea and intestine of cystic fibrosis mice causes inflammation and cell death.
    Becker KA; Tümmler B; Gulbins E; Grassmé H
    Biochem Biophys Res Commun; 2010 Dec; 403(3-4):368-74. PubMed ID: 21078296
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Gastrointestinal and metabolic impairments in cystic fibrosis].
    Grechanina EIa; Grechanina IuB; Ianovskaia AA
    Lik Sprava; 2014 Nov; (11):149-54. PubMed ID: 25528856
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Gastrointestinal complications of adult patients with cystic fibrosis].
    Bargon J; Stein J; Dietrich CF; Müller U; Caspary WF; Wagner TO
    Z Gastroenterol; 1999 Aug; 37(8):739-49. PubMed ID: 10494610
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) prevents apoptosis induced by hydrogen peroxide in basilar artery smooth muscle cells.
    Zeng JW; Zeng XL; Li FY; Ma MM; Yuan F; Liu J; Lv XF; Wang GL; Guan YY
    Apoptosis; 2014 Sep; 19(9):1317-29. PubMed ID: 24999019
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Selective activation of cystic fibrosis transmembrane conductance regulator Cl- and HCO3- conductances.
    Reddy MM; Quinton PM
    JOP; 2001 Jul; 2(4 Suppl):212-8. PubMed ID: 11875262
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cystic fibrosis-related diabetes: from CFTR dysfunction to oxidative stress.
    Ntimbane T; Comte B; Mailhot G; Berthiaume Y; Poitout V; Prentki M; Rabasa-Lhoret R; Levy E
    Clin Biochem Rev; 2009 Nov; 30(4):153-77. PubMed ID: 20011209
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Redox balance in cystic fibrosis.
    Ziady AG; Hansen J
    Int J Biochem Cell Biol; 2014 Jul; 52():113-23. PubMed ID: 24657650
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Estrogen and the cystic fibrosis gender gap.
    Saint-Criq V; Harvey BJ
    Steroids; 2014 Mar; 81():4-8. PubMed ID: 24342234
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Metabolic Syndrome as a Multifaceted Risk Factor for Oxidative Stress.
    Spahis S; Borys JM; Levy E
    Antioxid Redox Signal; 2017 Mar; 26(9):445-461. PubMed ID: 27302002
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Enigmatic Gut in Cystic Fibrosis: Linking Inflammation, Dysbiosis, and the Increased Risk of Malignancy.
    Garg M; Ooi CY
    Curr Gastroenterol Rep; 2017 Feb; 19(2):6. PubMed ID: 28155088
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Circulating biomarkers of antioxidant status and oxidative stress in people with cystic fibrosis: A systematic review and meta-analysis.
    Causer AJ; Shute JK; Cummings MH; Shepherd AI; Gruet M; Costello JT; Bailey S; Lindley M; Pearson C; Connett G; Allenby MI; Carroll MP; Daniels T; Saynor ZL
    Redox Biol; 2020 May; 32():101436. PubMed ID: 32044291
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.